Evidence map›Paper›PMID 30642383›Full record

ArticleIsrael journal of health policy research2019

IQOS point-of-sale marketing strategies in Israel: a pilot study.

Yael Bar-Zeev, Hagai Levine, Gil Rubinstein, Ihab Khateb, Carla J Berg

Abstract read
In one paragraph

Article in Israel journal of health policy research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Yael Bar-ZeevBraun School of Public Health and Community Medicine, Hadassah -Hebrew University, Jerusalem, Israel.
Hagai LevineBraun School of Public Health and Community Medicine, Hadassah -Hebrew University, Jerusalem, Israel.
Gil RubinsteinCentre for Smoking Cessation and Prevention, Division of Community Medicine, Faculty of Health, Ben-Gurion University, Beer-Sheva, Israel.
Ihab KhatebCentre for Smoking Cessation and Prevention, Division of Community Medicine, Faculty of Health, Ben-Gurion University, Beer-Sheva, Israel.
Carla J BergDepartment of Behavioral Sciences and Heath Education, Rollins School of Public Health, Winship Cancer Institute, Emory University Woodruff Health Sciences Center, 1518 Clifton Road, NE, Room 524, Atlanta, GA, 30322, USA. CJBerg@emory.edu.ORCID http://orcid.org/0000-0001-8931-1961

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS - Diversity SupplementR01CA215155 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J · 2018 to 2022
$3.4M
Market Research to Predict Emerging Tobacco Product Use in Diverse Young AdultsR01CA179422 · NCI · EMORY UNIVERSITY · PI BERG, CARLA J · 2013 to 2017
$2.7M
Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized TrialR01TW010664 · FIC · EMORY UNIVERSITY · PI BERG, CARLA J, KEGLER, MICHELLE C · 2017 to 2021
$1.5M
Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the USR01CA239178 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J, LEVINE, HAGAI · 2019 to 2021
$1.2M
FIC NIH HHS R01 TW010664NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA179422NCI NIH HHS R01 CA215155NCI NIH HHS R01 CA239178
6 · The paper itself

Abstract

backgroundPhilip Morris International's IQOS ("I Quit Ordinary Smoking") device has increasingly penetrated the global tobacco market. In Israel, among the first countries with IQOS in its market, the IQOS device is sold in specialty stores and online; the heat sticks - HEETS - are sold at traditional retailers. Advertising restrictions in many contexts including Israel have shifted industry marketing efforts to point-of-sale (POS). Given the nuances of IQOS and HEETS product distribution and the importance of POS marketing, we conducted a pilot study of IQOS POS marketing strategies.

methodsData collectors assessed product offerings, pricing, promotional strategies, and placement in a sample of 15 IQOS retailers (10 convenience stores, 3 grocery stores, 2 tobacco shops) in three Israeli cities (Beer-Sheva, Haifa, Jerusalem).

resultsAll retailers sold cigarettes; many carried other forms of tobacco (e.g., cigar products). Average price for a HEETS package was 30.2 Shekels (SD = 2.7); average price for the least expensive cigarette pack was 27.4 (SD = 1.5). HEETS were on average 9.5% more expensive than cigarettes. Posted ads were uncommon; rather, product displays were prominent. HEETS packages were often placed in a separate display box, at higher and more noticeable positions, and closer to consumers. Additionally, 11 retailers placed cigarettes and 10 placed HEETS near youth-oriented merchandise; 9 retailers placed cigarettes and HEETS, respectively, within 1 m of the floor.

conclusionsThis study represents an initial step in assessing IQOS POS practices - critical in advancing the ability to facilitate related research and regulation of emerging tobacco products in Israel and more broadly.

Indexed as

AdvertisingHealth PolicyHumansIsraelPilot ProjectsProduct LabelingTobacco ProductsENDSTobacco controlTobacco marketingTobacco policy

Identifiers

PMID30642383
PMCPMC6330751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.